Study of the Effectiveness of Ozurdex in Lieu of Oral Corticosteroids for the Control of Active Intermediate and Posterior Uveitis Requiring Immunosuppressive Drug Therapy

Trial Profile

Study of the Effectiveness of Ozurdex in Lieu of Oral Corticosteroids for the Control of Active Intermediate and Posterior Uveitis Requiring Immunosuppressive Drug Therapy

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2017

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Intermediate uveitis; Posterior uveitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.
    • 25 Feb 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018, according to ClinicalTrials.gov record.
    • 08 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top